Study to Examine the Safety, Tolerability and Pharmacokinetics of ascending doses of KNX100 in healthy volunteers.

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2025
This article has no abstract
Epistemonikos ID: 7a8fcdb5aa6c206ef57fbf8df26e601ac9c4716e
First added on: Mar 18, 2025